Phase II

Product attributes and development timeframes become defined. We’ll help you plan activities through to launch, including a comprehensive premarketing program, in anticipation of progression to phase III. Our expertise will help you enthuse thought leaders with the product’s potential, while using advisors to optimize study and communications activities.

As product characteristics and positioning become clearer, our medical knowledge, expertise and experience in the particular therapeutic area will help you refine product claims and messages. In line with your products and philosophy, product communications will be co-ordinated with portfolio activities. In the scientific literature, we’ll help build the data support for the product with carefully targeted placement of the first primary manuscripts together with continued exposure via abstracts and reviews. And other analyses will also include identification of thought leaders and other stakeholder advocates.

It’s vital that you have effective communication with the increasing range of stakeholder groups. During this phase we’ll also broaden our engagement with thought leaders and advisors. We’ll ensure you are receiving meaningful, objective advice from the best people in the world, while exposing key international advocates to your product’s potential, securing powerful advocacy for the future.